Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Am Fam Physician ; 98(2): 85-92, 2018 07 15.
Article in English | MEDLINE | ID: mdl-30215997

ABSTRACT

Approximately 10% of the U.S. population 12 years and older reported using illicit substances in 2015. This article reviews the clinical effects and treatment of persons who use cocaine, methamphetamines, 3,4-methylenedioxymethamphetamine (MDMA), synthetic cannabinoids, and synthetic cathinones ("bath salts"). Cocaine blocks the reuptake of the monoamine transporters dopamine, norepinephrine, and serotonin. Immediate clinical effects include increased energy and euphoria, as well as hypertension and arrhythmias. Acute myocardial infarction, seizures, hallucinations, hyperthermia, and movement disorders are among the possible adverse effects. Like cocaine, methamphetamine blocks reuptake of monoamine transporters, but also stimulates dopamine release and has a longer duration of action. Methamphetamine misuse is associated with severe dental problems. MDMA is a stimulant and psychedelic with a chemical structure similar to serotonin. Adverse effects include serotonin syndrome, hyponatremia, long-term memory impairment, and mood disorders. Synthetic cannabinoids can have a more intense and long-lasting effect than natural cannabis. Acute intoxication may cause severe cardiac and respiratory complications and seizures. Synthetic cathinones are marketed as cheap substitutes for other stimulants. Their effects are similar to those of other stimulants, and they are addictive. Psychosocial intervention is the main form of treatment for addiction to these substances. Promising therapies include disulfiram and substitution therapy for cocaine misuse disorders, and mirtazapine for methamphetamine use disorder.


Subject(s)
Designer Drugs/adverse effects , Primary Health Care/methods , Alkaloids/adverse effects , Alkaloids/pharmacology , Amphetamine-Related Disorders/diagnosis , Amphetamine-Related Disorders/therapy , Cannabinoids/adverse effects , Cannabinoids/pharmacology , Central Nervous System Stimulants/adverse effects , Cocaine-Related Disorders/diagnosis , Cocaine-Related Disorders/therapy , Counseling/methods , Crack Cocaine/adverse effects , Crack Cocaine/pharmacology , Designer Drugs/pharmacology , Humans , Methamphetamine/adverse effects , Methamphetamine/pharmacology , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Psychotropic Drugs/adverse effects , Psychotropic Drugs/pharmacology
3.
Fam Med ; 44(9): 650-3, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23027158

ABSTRACT

BACKGROUND AND OBJECTIVES: The study objective was to determine the influence of the 2001 and 2006 American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines changes on colposcopy training at one family medicine residency. METHODS: We conducted a retrospective chart review from January 1, 2000 to October 31, 2009. The 2001 ASCCP guidelines were fully implemented into our practice in June 2002 and the 2006 guidelines in June 2008. Data were extracted from our electronic medical records and delineated into three groups: 2000-2002 (pre-2001 guideline changes), 2003-2007 (post-2001 and pre-2006 update), and 2008-2009 (post 2006 changes) for total female patient visits aged 18-75 years, pap smears, and colposcopies. An ANOVA post-hoc comparison test was performed on the three data groups to test significance. RESULTS: After the 2001 guidelines, there was a 28.6% significant decrease in colposcopies (CI=0.20-0.37). An additional, 16.5% significant decrease occurred after the 2006 revisions (CI=0.06-0.28). Consequently, residents performed 45.1% fewer colposcopies. The total number of pap smears remained relatively unchanged. CONCLUSIONS: Implementation of the 2001 and 2006 ASCCP guidelines significantly reduced the number colposcopies performed, resulting in greater difficulty training competent family medicine residents in colposcopy.


Subject(s)
Colposcopy/education , Family Practice/education , Internship and Residency , Practice Guidelines as Topic , Adolescent , Adult , Aged , Analysis of Variance , Colposcopy/statistics & numerical data , Female , Florida , Guideline Adherence , Humans , Medical Audit , Middle Aged , Retrospective Studies , Societies, Medical/standards , Young Adult
4.
Clin Pediatr (Phila) ; 51(1): 31-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21885433

ABSTRACT

BACKGROUND: Overweight children are often not identified or counseled. PURPOSE: We assessed the documentation rate and clinical management of overweight children before and after an electronic medical record (EMR) upgrade calculating body mass index (BMI) percentile for age and gender. METHODS: Family Medicine resident and faculty physicians at two sites received an EMR upgrade; Site 1 physicians also received BMI training and education. From two years before to one year after the upgrade, randomly selected charts were reviewed for all encounters with overweight children for documentation of obesity and clinical management. RESULTS: After the EMR upgrade, documentation and counseling rates significantly improved at both sites but the rate of change was greater for Site 1; postintervention documentation was significantly greater for Site 1 vs. Site 2 (40% vs. 28%, P<0.01). CONCLUSIONS: We found an increase in documentation and management of overweight children following an EMR upgrade that calculates BMI percentiles for age and gender. Physician education was an important adjunct.


Subject(s)
Documentation , Electronic Health Records , Family Practice/education , Inservice Training , Obesity/prevention & control , Algorithms , Analysis of Variance , Body Mass Index , Chi-Square Distribution , Child , Decision Support Techniques , Female , Humans , Male , Overweight/prevention & control
5.
FP Essent ; 398: 1-6, 10-35; quiz 7-9, 36-41, 2012 Jul.
Article in English | MEDLINE | ID: mdl-23547401
SELECTION OF CITATIONS
SEARCH DETAIL
...